Impact of VALID Act implementation on mass spectrometry-based clinical proteomic laboratory developed tests

Mass spectrometry (MS)-based clinical proteomic Laboratory Developed Tests (LDTs) for the measurement of protein biomarkers related to endocrinology, cardiovascular disease, cancer, and Alzheimer’s disease are gaining traction in clinical laboratories due to their value in supporting diagnostic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yanchun, Thomas, Stefani N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971545/
https://www.ncbi.nlm.nih.gov/pubmed/36865788
http://dx.doi.org/10.1016/j.jmsacl.2023.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971545/
https://www.ncbi.nlm.nih.gov/pubmed/36865788
http://dx.doi.org/10.1016/j.jmsacl.2023.02.001

Ejemplares similares